Hologic Statistics
Total Valuation
Hologic has a market cap or net worth of $16.28 billion. The enterprise value is $16.60 billion.
| Market Cap | 16.28B |
| Enterprise Value | 16.60B |
Important Dates
The next confirmed earnings date is Wednesday, February 5, 2025, after market close.
| Earnings Date | Feb 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Hologic has 225.72 million shares outstanding. The number of shares has decreased by -4.53% in one year.
| Current Share Class | 225.72M |
| Shares Outstanding | 225.72M |
| Shares Change (YoY) | -4.53% |
| Shares Change (QoQ) | -0.21% |
| Owned by Insiders (%) | 0.81% |
| Owned by Institutions (%) | 105.29% |
| Float | 223.66M |
Valuation Ratios
The trailing PE ratio is 21.73 and the forward PE ratio is 16.95. Hologic's PEG ratio is 1.85.
| PE Ratio | 21.73 |
| Forward PE | 16.95 |
| PS Ratio | 4.22 |
| Forward PS | 3.82 |
| PB Ratio | 3.26 |
| P/TBV Ratio | 19.33 |
| P/FCF Ratio | 14.10 |
| P/OCF Ratio | 12.67 |
| PEG Ratio | 1.85 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.05, with an EV/FCF ratio of 14.38.
| EV / Earnings | 21.03 |
| EV / Sales | 4.12 |
| EV / EBITDA | 13.05 |
| EV / EBIT | 17.11 |
| EV / FCF | 14.38 |
Financial Position
The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.52.
| Current Ratio | 3.69 |
| Quick Ratio | 2.83 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 2.02 |
| Debt / FCF | 2.30 |
| Interest Coverage | 7.95 |
Financial Efficiency
Return on equity (ROE) is 15.56% and return on invested capital (ROIC) is 7.72%.
| Return on Equity (ROE) | 15.56% |
| Return on Assets (ROA) | 6.63% |
| Return on Invested Capital (ROIC) | 7.72% |
| Return on Capital Employed (ROCE) | 11.95% |
| Revenue Per Employee | $576,581 |
| Profits Per Employee | $112,947 |
| Employee Count | 6,990 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.44 |
Taxes
In the past 12 months, Hologic has paid $75.60 million in taxes.
| Income Tax | 75.60M |
| Effective Tax Rate | 8.74% |
Stock Price Statistics
The stock price has decreased by -3.72% in the last 52 weeks. The beta is 0.98, so Hologic's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | -3.72% |
| 50-Day Moving Average | 73.88 |
| 200-Day Moving Average | 77.09 |
| Relative Strength Index (RSI) | 50.11 |
| Average Volume (20 Days) | 2,345,887 |
Short Selling Information
The latest short interest is 5.60 million, so 2.48% of the outstanding shares have been sold short.
| Short Interest | 5.60M |
| Short Previous Month | 5.51M |
| Short % of Shares Out | 2.48% |
| Short % of Float | 2.51% |
| Short Ratio (days to cover) | 3.55 |
Income Statement
In the last 12 months, Hologic had revenue of $4.03 billion and earned $789.50 million in profits. Earnings per share was $3.32.
| Revenue | 4.03B |
| Gross Profit | 2.45B |
| Operating Income | 970.20M |
| Pretax Income | 789.10M |
| Net Income | 789.50M |
| EBITDA | 1.27B |
| EBIT | 970.20M |
| Earnings Per Share (EPS) | $3.32 |
Balance Sheet
The company has $2.34 billion in cash and $2.66 billion in debt, giving a net cash position of -$321.30 million or -$1.42 per share.
| Cash & Cash Equivalents | 2.34B |
| Total Debt | 2.66B |
| Net Cash | -321.30M |
| Net Cash Per Share | -$1.42 |
| Equity (Book Value) | 5.13B |
| Book Value Per Share | 22.14 |
| Working Capital | 2.79B |
Cash Flow
In the last 12 months, operating cash flow was $1.29 billion and capital expenditures -$130.20 million, giving a free cash flow of $1.16 billion.
| Operating Cash Flow | 1.29B |
| Capital Expenditures | -130.20M |
| Free Cash Flow | 1.16B |
| FCF Per Share | $5.12 |
Margins
Gross margin is 60.73%, with operating and profit margins of 24.07% and 19.59%.
| Gross Margin | 60.73% |
| Operating Margin | 24.07% |
| Pretax Margin | 21.46% |
| Profit Margin | 19.59% |
| EBITDA Margin | 31.56% |
| EBIT Margin | 24.07% |
| FCF Margin | 28.66% |
Dividends & Yields
Hologic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.53% |
| Shareholder Yield | 4.53% |
| Earnings Yield | 4.85% |
| FCF Yield | 7.09% |
Analyst Forecast
The average price target for Hologic is $88.92, which is 23.26% higher than the current price. The consensus rating is "Buy".
| Price Target | $88.92 |
| Price Target Difference | 23.26% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 4.85% |
| EPS Growth Forecast (5Y) | 10.30% |
Stock Splits
The last stock split was on April 3, 2008. It was a forward split with a ratio of 2:1.
| Last Split Date | Apr 3, 2008 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Hologic has an Altman Z-Score of 4.22 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.22 |
| Piotroski F-Score | 6 |